首页 › 基金 › LuminArx Capital Management LP › HUMA
LuminArx Capital Management LP 对 HUMA 的持仓历史
HUMACYTE INC · 医疗保健
LuminArx Capital Management LP 在 Q2 2026 的 13F 申报中披露持有 HUMA(HUMACYTE INC)650,000 股,市值约 US$507K,约占其申报组合的 0.54%,在其申报持仓中市值排名第 39 位。 LuminArx Capital Management LP 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
LuminArx Capital Management LP 对 HUMA 的持仓演变
LuminArx Capital Management LP 于 Q2 2026 首次披露 HUMA 持仓:650,000 股(约 US$507K)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 650.00K | $507.26K | 新进 |
关于 HUMA 与 13F 数据
HUMA(HUMACYTE INC)属于医疗保健行业。我们追踪的基金中还有 26 只申报持有 HUMA,申报仓位最大的包括:GREAT POINT PARTNERS LLC (US$2.9M), Lion Point Capital, LP (US$507K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 HUMA 的基金
- GREAT POINT PARTNERS LLC 3.75M 股 · $2.93M · Q2 2026
- Lion Point Capital, LP 650.00K 股 · $507.26K · Q2 2026
更多关于 LuminArx Capital Management LP
常见问题
How long has LuminArx Capital Management LP held HUMA?
LuminArx Capital Management LP has disclosed HUMA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is LuminArx Capital Management LP's current position in HUMA?
As of Q2 2026, LuminArx Capital Management LP holds 650.00K shares of HUMA (HUMACYTE INC), valued at $507.26K, representing 0.54% of its reported portfolio and ranking #39.
Has LuminArx Capital Management LP been buying or selling HUMA?
In the latest 13F filing (Q2 2026), LuminArx Capital Management LP newly opened its position in HUMA.
Which other funds hold HUMA?
Other major institutional holders of HUMA include GREAT POINT PARTNERS LLC, Lion Point Capital, LP, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.